Tower Research Capital (TRC)’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,069
| Closed | -$46.6K | – | 6483 |
|
|
2023
Q2 | $46.6K | Buy |
2,069
+1,037
| +100% | +$23.3K | ﹤0.01% | 2623 |
|
|
2023
Q1 | $12K | Buy |
1,032
+92
| +10% | +$1.07K | ﹤0.01% | 4165 |
|
|
2022
Q4 | $4K | Sell |
940
-41
| -4% | -$174 | ﹤0.01% | 5129 |
|
|
2022
Q3 | $6K | Buy |
981
+705
| +255% | +$4.31K | ﹤0.01% | 5100 |
|
|
2022
Q2 | $3K | Sell |
276
-445
| -62% | -$4.84K | ﹤0.01% | 5461 |
|
|
2022
Q1 | $14K | Buy |
721
+436
| +153% | +$8.47K | ﹤0.01% | 3938 |
|
|
2021
Q4 | $10K | Sell |
285
-64
| -18% | -$2.25K | ﹤0.01% | 4644 |
|
|
2021
Q3 | $26K | Buy |
349
+252
| +260% | +$18.8K | ﹤0.01% | 3501 |
|
|
2021
Q2 | $13K | Buy |
97
+33
| +52% | +$4.42K | ﹤0.01% | 4254 |
|
|
2021
Q1 | $19K | Buy |
+64
| New | +$19K | ﹤0.01% | 3943 |
|